U.S. FDA approves Gilead cell therapy for earlier lymphoma ...Middle East

Devdiscourse - Opinion
U.S. FDA approves Gilead cell therapy for earlier lymphoma
The U.S. Food and Drug Administration on Friday said it had approved expanded use of Gilead Sciences Inc's Yescarta cell therapy as a first option after chemotherapy for adults with an advanced, aggressive form of blood cancer.

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA approves Gilead cell therapy for earlier lymphoma )

Also on site :

Most viewed in Opinion


Latest News